New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M
New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M is a paper indexed in ScholarIQ from OpenAlex.
How many citations does New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M have?
New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M has 141 citations in the OpenAlex counts ScholarIQ stores.
When was New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M published?
New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M has 2017 year in the ScholarIQ index.
What is the open-access status of New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M?
New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M has closed oa status in the ScholarIQ index.
What is the DOI of New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M?
The DOI for New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M is on the source record.
What is the PMID of New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M?
The PMID for New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M is on the source record.
What is the OpenAlex record for New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M?
The OpenAlex for New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M is on the source record.